ATE394378T1 - Phenanthridin -n- oxide - Google Patents
Phenanthridin -n- oxideInfo
- Publication number
- ATE394378T1 ATE394378T1 AT01909597T AT01909597T ATE394378T1 AT E394378 T1 ATE394378 T1 AT E394378T1 AT 01909597 T AT01909597 T AT 01909597T AT 01909597 T AT01909597 T AT 01909597T AT E394378 T1 ATE394378 T1 AT E394378T1
- Authority
- AT
- Austria
- Prior art keywords
- alkoxy
- oxides
- substituted
- phenanthridine
- cycloalkylmethoxy
- Prior art date
Links
- RDOWQLZANAYVLL-UHFFFAOYSA-N phenanthridine Chemical compound C1=CC=C2C3=CC=CC=C3C=NC2=C1 RDOWQLZANAYVLL-UHFFFAOYSA-N 0.000 title 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/10—Aza-phenanthrenes
- C07D221/12—Phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Reproductive Health (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00100482 | 2000-01-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE394378T1 true ATE394378T1 (de) | 2008-05-15 |
Family
ID=8167598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01909597T ATE394378T1 (de) | 2000-01-11 | 2001-01-10 | Phenanthridin -n- oxide |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6630483B2 (de) |
| EP (1) | EP1250325B1 (de) |
| JP (1) | JP2003519686A (de) |
| AT (1) | ATE394378T1 (de) |
| AU (1) | AU782908B2 (de) |
| CA (1) | CA2396026A1 (de) |
| DE (1) | DE60133879D1 (de) |
| WO (1) | WO2001051470A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE288430T1 (de) | 2000-07-14 | 2005-02-15 | Altana Pharma Ag | 6-heteroarylphenanthridine |
| AU2003255493B8 (en) * | 2002-08-29 | 2009-03-26 | Takeda Gmbh | 2-hydroxy-6-phenylphenanthridines as PDE-4 inhibitors |
| US7423046B2 (en) * | 2002-08-29 | 2008-09-09 | Nycomed Gmbh | 3-hydroxy-6-phenylphenanthridines as pde-4 inhibitors |
| SG182194A1 (en) | 2004-03-03 | 2012-07-30 | Nycomed Gmbh | Novel hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors |
| SI1856093T1 (sl) | 2005-03-02 | 2010-03-31 | Nycomed Gmbh | Hidrokloridna sol R aR bR dimetoksipiridin il etoksi metoksi a b heksahidrofenantridin ola |
| JP4643543B2 (ja) * | 2006-11-10 | 2011-03-02 | 株式会社東芝 | キャッシュ一貫性保証機能を有するストレージクラスタシステム |
| WO2009043784A1 (en) | 2007-10-04 | 2009-04-09 | F. Hoffmann-La Roche Ag | Cyclopropyl aryl amide derivatives and uses thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4761403A (en) * | 1986-04-09 | 1988-08-02 | Abbott Laboratories | Lipoxygenase inhibiting compounds |
| BR9707233A (pt) | 1996-01-31 | 1999-07-20 | Byk Gulden Lomberg Chem Fab | Fenantridinas |
| US6127378A (en) | 1996-03-26 | 2000-10-03 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Phenanthridines substituted in the 6 position |
| EP0889886B1 (de) * | 1996-03-26 | 2002-09-18 | ALTANA Pharma AG | Neue in 6-position substituierte phenanthridine |
| PL190685B1 (pl) | 1997-07-25 | 2005-12-30 | Altana Pharma Ag | Nowe pochodne tetrazolu, środek farmaceutyczny oraz zastosowanie |
| ES2189235T3 (es) * | 1997-07-25 | 2003-07-01 | Altana Pharma Ag | 6-fenilfenantridinas sustituidas. |
| SI1075477T1 (en) | 1998-05-05 | 2003-08-31 | Altana Pharma Ag | Novel Benzonaphthyridine-N-oxides |
| JP2002523505A (ja) | 1998-08-31 | 2002-07-30 | ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング | Ｐｄｅ３−及びｐｄｅ−４抑制作用を有するベンゾナフチリデン−ｎ−オキシド |
| WO2000042017A1 (en) | 1999-01-15 | 2000-07-20 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Phenanthridine-n-oxides with pde-iv inhibiting activity |
| CA2359449A1 (en) | 1999-01-15 | 2000-07-20 | Beate Gutterer | Phenanthridine-n-oxides with pde-iv inhibiting activity |
-
2001
- 2001-01-10 EP EP01909597A patent/EP1250325B1/de not_active Expired - Lifetime
- 2001-01-10 WO PCT/EP2001/000223 patent/WO2001051470A1/en not_active Ceased
- 2001-01-10 AU AU37283/01A patent/AU782908B2/en not_active Ceased
- 2001-01-10 US US10/149,965 patent/US6630483B2/en not_active Expired - Fee Related
- 2001-01-10 CA CA002396026A patent/CA2396026A1/en not_active Abandoned
- 2001-01-10 DE DE60133879T patent/DE60133879D1/de not_active Expired - Fee Related
- 2001-01-10 AT AT01909597T patent/ATE394378T1/de not_active IP Right Cessation
- 2001-01-10 JP JP2001551852A patent/JP2003519686A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| US6630483B2 (en) | 2003-10-07 |
| US20030105123A1 (en) | 2003-06-05 |
| EP1250325B1 (de) | 2008-05-07 |
| CA2396026A1 (en) | 2001-07-19 |
| JP2003519686A (ja) | 2003-06-24 |
| DE60133879D1 (de) | 2008-06-19 |
| WO2001051470A1 (en) | 2001-07-19 |
| AU3728301A (en) | 2001-07-24 |
| AU782908B2 (en) | 2005-09-08 |
| EP1250325A1 (de) | 2002-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9707233A (pt) | Fenantridinas | |
| MY135732A (en) | 5,6-trimethylenepyrimidin - 4 - one compounds | |
| MY135766A (en) | Quinolinones and naphthyridinones for treating inflammatory diseases | |
| DK1070056T3 (da) | Phthalazinon-PDE III/IV-inhibitorer | |
| DK0889886T3 (da) | Hidtil ukendte, i 6-stilling substituerede phenanthridiner | |
| DK0937074T3 (da) | Benzonaphthyridiner som bronkiale terapeutiske midler | |
| UA88463C2 (ru) | Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции | |
| DE60318826D1 (de) | Alkoxypyridinderivate | |
| WO2001078653A3 (en) | Graft rejection inhibition with ccr2 inhibitors | |
| WO2003015708A8 (en) | Composition and method for treating hiv infection | |
| PT1147103E (pt) | Fenantridina-n-oxidos com actividade inibitoria de pde-iv | |
| WO2005087745A8 (en) | Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors | |
| DE60133879D1 (de) | Phenanthridin -n- oxide | |
| PT1147088E (pt) | 6-arilfenantridinas com actividade inibitoria da pde-iv | |
| ATE295352T1 (de) | Phenanthridine-n-oxide mit pde-iv hemmender wirkung | |
| WO2005087744A8 (en) | Novel thio-containing hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors | |
| TR200302134T4 (tr) | 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı. | |
| AU6539900A (en) | Thiophene-ethyl thiourea compounds and their use in the treatment of hiv | |
| SI0937075T1 (en) | New Imidazo- and Oxazolopyridines as Phosphodiesterase Inhibitors. | |
| AU758194C (en) | Novel benzimidazoles and benzoxazoles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |